Pacific Biometrics Inc. Is Delisted by Nasdaq
- Share via
The Nasdaq market delisted Pacific Biometrics Inc.’s stock Monday after determining that the Lake Forest medical company failed to meet listing standards.
The company said the stock may trade over-the-counter, but that the delisting may make it more difficult to raise additional capital. Pacific Biometrics is developing methods for early detection and management of osteoporosis and diabetes.
The stock, which has failed to meet Nasdaq’s minimum listing price of $1 a share, last traded on Friday at 28 cents a share.
Several Orange County stocks that have fallen below $1 a share are facing similar fates.
Inside the business of entertainment
The Wide Shot brings you news, analysis and insights on everything from streaming wars to production — and what it all means for the future.
You may occasionally receive promotional content from the Los Angeles Times.
